MCMS Member Richard Heuser, MD to Present at Annual American Heart Association's Scientific Session Meeting
On November 13, 2011, Richard R. Heuser, M.D., FACC, FACP, FESC, FSCAI, Chief of Cardiology at St. Luke’s Medical Center and Clinical Professor of Medicine at the University of Arizona College of Medicine, will present at the American Heart Association's (AHA) yearly scientific session meeting in Orlando, Florida. Dr. Heuser has been honored to present yearly at the AHA meeting since the early ‘80s. He will be presenting a paper on the "Advanced Antegrade Approach to CTO's: New Technique and Devices to Improve Success and Safety", for the treatment of chronically 100 percent occluded coronary arteries.
Dr. Heuser is a founding member of the CTO Club. He was the first cardiologist in Arizona to report in United States literature the development and technique of using a catheter to open up a chronically occluded heart artery through a patient’s vessel downstream, supplying collaterals to the occluded artery. He also co-invented the first hydrophilic wire in 1993 that is used in about 20 percent of all angioplasties worldwide.
Dr. Heuser hosts training courses for CTO treatments for physicians in the Valley and nationwide. He frequently presents techniques developed in Phoenix at interventional meetings. He will be discussing not only techniques to safely treat these patients, but will present a new device he has developed and patented that is currently pending approval. It should be available worldwide within the next year.
“The main reason patients undergo bypass surgery these days is because of at least one percent blocked heart arteries. We think that the techniques that we have developed will make these complex procedures more readily applied for our patients, with the eventual approval and acceptance of this device for patients worldwide. It is always an honor to be the Phoenix representative at this prestigious meeting as a teacher to other cardiovascular researchers, but to be part of the AHA's campaign to combat the nation's #1 killer, coronary artery disease,” says Dr. Heuser.
The AHA meeting in Orlando is the largest interventional cardiology meeting attended by approximately 40,000 cardiovascular specialists from around the world.
